Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sarah Pinder is active.

Publication


Featured researches published by Sarah Pinder.


Nature | 2017

Somatic mutations reveal asymmetric cellular dynamics in the early human embryo

Young Seok Ju; Inigo Martincorena; Moritz Gerstung; Mia Petljak; Ludmil B. Alexandrov; Raheleh Rahbari; David C. Wedge; Helen Davies; Manasa Ramakrishna; Anthony Fullam; Sancha Martin; Christopher Alder; Nikita Patel; Steve Gamble; Sarah O'Meara; Dilip Giri; Torril Sauer; Sarah Pinder; Colin A. Purdie; Åke Borg; Henk Stunnenberg; Marc J. van de Vijver; Benita Kiat Tee Bk Tan; Carlos Caldas; Andrew Tutt; Naoto Ueno; Laura J. van 't Veer; John W.M. Martens; Christos Sotiriou; Stian Knappskog

Somatic cells acquire mutations throughout the course of an individual’s life. Mutations occurring early in embryogenesis are often present in a substantial proportion of, but not all, cells in postnatal humans and thus have particular characteristics and effects. Depending on their location in the genome and the proportion of cells they are present in, these mosaic mutations can cause a wide range of genetic disease syndromes and predispose carriers to cancer. They have a high chance of being transmitted to offspring as de novo germline mutations and, in principle, can provide insights into early human embryonic cell lineages and their contributions to adult tissues. Although it is known that gross chromosomal abnormalities are remarkably common in early human embryos, our understanding of early embryonic somatic mutations is very limited. Here we use whole-genome sequences of normal blood from 241 adults to identify 163 early embryonic mutations. We estimate that approximately three base substitution mutations occur per cell per cell-doubling event in early human embryogenesis and these are mainly attributable to two known mutational signatures. We used the mutations to reconstruct developmental lineages of adult cells and demonstrate that the two daughter cells of many early embryonic cell-doubling events contribute asymmetrically to adult blood at an approximately 2:1 ratio. This study therefore provides insights into the mutation rates, mutational processes and developmental outcomes of cell dynamics that operate during early human embryogenesis.


Archive | 2017

Additional file 6: Table S3. of Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study

Katherine Lawler; Efterpi Papouli; Cristina Naceur-Lombardelli; Anca Mera; Kayleigh Ougham; Andrew Tutt; Siker Kimbung; Ingrid Hedenfalk; Jun Zhan; Hongquan Zhang; Richard Buus; Mitch Dowsett; Tony Ng; Sarah Pinder; Peter Parker; Lars Holmberg; C Gillett; Anita Grigoriadis; Arnie Purushotham

Distribution of gene module scores for cases and controls in each case-control series, and estimated ORs using conditional logistic and logistic regression models. (XLSX 47 kb)


Ejc Supplements | 2007

O-91 Prognostic estimation: re-analysis of data from cases diagnosed in 1990–99 by Cox proportional hazards method

R. W. Blamey; M.J. Mitchell; Graham Ball; A.R. Green; Raj Rampaul; Sarah Pinder; Andrew H S Lee; R.D. Macmillan; I.O. Ellis


European Journal of Cancer | 2018

Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project.

Alastair M. Thompson; K Clements; Shan Cheung; Sarah Pinder; G Lawrence; Elinor Sawyer; Olive Kearins; Graham Ball; Ian Tomlinson; Andrew M. Hanby; Jeremy Thomas; A Maxwell; Matthew G. Wallis; David Dodwell; Alastair Thompson; Adele Francis; Mark Sibbering; H. Bishop; Robert Carpenter; W.D. George; Martin S. Lee; Stewart Nicholson; Hilary M Dobson; Andrew Evans; Anthony Maxwell; D. Dodwell; Julian Adlard; John Dewar; Gillian Ross; Maggie Wilcox


Archive | 2017

Additional file 3: of Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study

Katherine Lawler; Efterpi Papouli; Cristina Naceur-Lombardelli; Anca Mera; Kayleigh Ougham; Andrew Tutt; Siker Kimbung; Ingrid Hedenfalk; Jun Zhan; Hongquan Zhang; Richard Buus; Mitch Dowsett; Tony Ng; Sarah Pinder; Peter Parker; Lars Holmberg; C Gillett; Anita Grigoriadis; Arnie Purushotham


Archive | 2014

Supplementary Materials for The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility

Tai Kiuchi; Elena Ortiz-Zapater; James Monypenny; Daniel R. Matthews; Lan K. Nguyen; Jody Barbeau; Oana Coban; Brian Burford; Daniel J. Rolfe; Dimitra Dafo; Michael A. Simpson; Sarah Pinder; C Gillett; Viviane Devauges; Simon P. Poland; Pierfrancesco Marra; Ykelien L. Boersma; Andreas Plückthun; Yosef Yarden; George Santis; Martyn Winn; Boris N. Kholodenko; Peter Parker; Andrew Tutt; Simon Ameer-Beg; Tony Ng


Archive | 2013

Histological risk factors, prognostic indicators and staging

Emad A. Rakha; Sarah Pinder; Ian O. Ellis


Ejc Supplements | 2010

O-68 The effect of lymphovascular invasion (LVI) on survival

R. W. Blamey; M. Sundquist; S. Bianchi; A. Douglas-Jones; I.O. Ellis; Andrew H S Lee; Sarah Pinder; S. Thorstenson; Graham Ball


Ejc Supplements | 2010

145 A rescoring of Elston-Ellis Grade improves prognostic discrimination and consistency

R.W. Blamey; B. Hornmark-Stenstam; S. Bianchi; T. Kuukasjarvi; Sarah Pinder; F. Rank; Graham Ball; I.O. Ellis


Ejc Supplements | 2007

O-62 External validation in ONCOPOOL of updated survival according to the Nottingham Prognostic Index (NPI)

K. Holli; R.W. Blamey; M.J. Mitchell; M. Blichert-Toft; L. Cataliotti; Ian O. Ellis; A. Fourquet; B. Hornmark-Stenstam; R. Jakesz; Michael J. Kerin; I. Monypenny; R. Nicholson; M. Peterse; Sarah Pinder; M. Sundquist; E. Towpik; M.J. van de Vijver

Collaboration


Dive into the Sarah Pinder's collaboration.

Top Co-Authors

Avatar

Graham Ball

Nottingham Trent University

View shared research outputs
Top Co-Authors

Avatar

I.O. Ellis

University of Nottingham

View shared research outputs
Top Co-Authors

Avatar

R.W. Blamey

University of Nottingham

View shared research outputs
Top Co-Authors

Avatar

Andrew Tutt

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ian O. Ellis

University of Nottingham

View shared research outputs
Top Co-Authors

Avatar

M. Sundquist

Nottingham City Hospital

View shared research outputs
Top Co-Authors

Avatar

Peter Parker

Francis Crick Institute

View shared research outputs
Top Co-Authors

Avatar

Tony Ng

King's College London

View shared research outputs
Researchain Logo
Decentralizing Knowledge